Dr. Reddy's API Manufacturing Capabilities:
Dr. Reddy’s manufactures over 250+ APIs across India, Mexico, and the UK, with eight USFDA-inspected cGMP facilities that comply with ICH Q7 guidelines and are regularly audited by global regulators. With 40+ years of expertise, the company specializes in complex APIs such as steroids, peptides, long-chain molecules, and HPAPIs, supported by robust R&D and worldwide commercialization capabilities.
Focused on becoming the leading global API company, Dr. Reddy’s emphasizes innovation, a strong global footprint, and exceptional customer service. With multi-sourced KSMs, stringent quality standards, timely deliveries, and capacity expansion, the company ensures a reliable, sustainable supply chain, combining scientific expertise, compliance, and sustainability to be a trusted API partner.

Loading manufacturing data...

Quality Control Policies
A key component in quality control in pharmaceutical industry is helping customers by providing a quality product. We achieve this by ensuring that all our facilities operate efficiently and to the latest quality, safety, and productivity standards.
At Dr. Reddy’s, quality control is central to our commitment to delivering safe, high-quality APIs. Our facilities operate under cGMP (ICH Q7) standards, ensuring global regulatory compliance and consistent product performance.
Advanced Analytical & Process Excellence
- Scalable manufacturing for consistent quality
- Robust analytical methods to eliminate nitrosamine and azido impurities
- Comprehensive impurity profiling, characterization, and control
- Use of advanced techniques to define chemical and physical attributes
- Efficient operations aligned with the latest quality, safety, and productivity standards
Descargo de responsabilidad
Ninguna información en este sitio web, incluyendo cualquier referencia a cualquier producto o servicio, constituye una oferta de venta ni se interpretará como tal. Los productos protegidos por patentes válidas no se ofrecen ni suministran para uso comercial. Sin embargo, en ciertos casos, a discreción exclusiva de Dr. Reddy's y sujeto a los requisitos legales locales, las cantidades de investigación de dichos productos pueden ofrecerse para fines de presentaciones regulatorias según la Sección 107A de la Ley de Patentes de la India (exención de Bolar), donde existan dichas exenciones regulatorias. Los compradores deben realizar su propia evaluación del producto o servicio, incluyendo el escenario de patentes en sus respectivos mercados, y serán responsables de todas las responsabilidades relacionadas con las patentes. Dr. Reddy's renuncia a todas las garantías, expresas o implícitas, incluyendo, entre otras, las garantías de comerciabilidad, idoneidad para un propósito particular y no infracción.









